menu search

Pantheon vision raises $2.5 million in seed funding to launch development of bioengineered corneal implant

The medical device startup is focused on addressing significant unmet needs of patients suffering from corneal...

November 2, 2023, 6:06 pm

corneal implants market forecasted to reach $794 million by 2032 amid growing prevalence of corneal disorders: persistence market research

The human cornea dominates the global market with over 92% demand, outperforming synthetic corneas. Expect sustained growth in this sector throughout ...

October 27, 2023, 5:21 am

Bsf enterprise flutters higher as lab-grown cornea subsidiary created

BSF Enterprise PLC (LSE:BSFA) shares fluttered 8% higher to 8.2% after the bio-tissues company formed a division to focus on lab-grown corneas. Kerato...

October 26, 2023, 4:03 am

Okyo pharma files ind application ok-101 to treat neuropathic corneal pain

OKYO Pharma Ltd (NASDAQ:OKYO), the clinical-stage drug developer noted, told investors it has filed an Investigational New Drug (IND) application wit...

October 9, 2023, 8:20 am

Okyo pharma inks collaboration with tufts medical center

OKYO Pharma Ltd (NASDAQ:OKYO) has revealed a new partnership with Tufts Medical Center to conduct an open-label clinical trial to assess the efficacy ...

July 28, 2023, 8:11 am

Societal cdmo selected by xequel bio to provide cdmo services to support ongoing clinical development of inexin™

Activities Focused on Xequel’s Ophthalmic Solution Containing aCT1 Peptide, Being Developed for the Treatment of Persistent ...

May 8, 2023, 11:00 am

Okyo pharma to address key conference with data on dry eye drug

OKYO Pharma Ltd (LSE:OKYO, NASDAQ:OKYO), an ophthalmology-focused biopharmaceutical company, will showcase two presentations on its dry eye disease (D...

May 3, 2023, 2:24 am

Kala up on fast track designation to lead ocular candidate

KALA gets Fast Track Designation from the FDA for lead candidate KPI-012 to treat persistent corneal ep...

April 13, 2023, 12:56 pm

Kala pharma: rare eye disease biotech lottery ticket based on stem cell platform

FDA Accepted IND Filing for the company to initiate a phase 2b study using KPI-012 for the treatment of patients with the persistent ...

January 19, 2023, 7:12 am

Amber ophthalmics announces positive topline phase 2 data evaluating nexagon® for the treatment of persistent corneal epithelial defect (pced)

••Complete epithelial recovery was achieved by 67% of subjects receiving NEXAGON, as opposed to 27% receiving Vehicle alone••NEXAGON was well-...

January 9, 2023, 12:31 pm

: kala pharmaceuticals stock up 750% in 3 days after upbeat fda news on pced treatment

Shares of Kala Pharmaceuticals Inc. KALA have rocketed higher in for three-straight sessions, toward a more-than 8-fold gain, since the biopharmaceuti...

December 30, 2022, 5:02 pm

Kala pharmaceuticals stock up 750% in 3 days after upbeat fda news on pced treatment

Shares of Kala Pharmaceuticals Inc. KALA, +39.53% have rocketed higher in for three-straight sessions, toward a more-than 8-fold gain, since the bioph...

December 30, 2022, 12:02 pm

Kala pharmaceuticals stock continues to soar: what's going on? - kala pharmaceuticals (nasdaq:kala)

Kala Pharmaceuticals Inc KALA shares are trading higher Thursday. The stock appears to be moving on continued momentum after the company on Wednesday...

December 29, 2022, 8:30 am

: kala pharmaceuticals stock rockets nearly 300% after fda oks ind application for pced treatment

Shares of Kala Pharmaceuticals Inc. KALA quadrupled in very volatile trading Wednesday, after the biopharmaceutical company said the Food and Drug Adm...

December 28, 2022, 5:44 pm

Kala pharmaceuticals (kala) up as fda accepts ind for kpi-012

The FDA accepts Kala Pharmaceuticals' (KALA) investigational new drug application for pipeline candidate KPI-012 for treating persistent ...

December 28, 2022, 12:21 pm

Kala pharmaceuticals stock rockets after fda accepts ind application for pced treatment

Shares of Kala Pharmaceuticals Inc. KALA, +1.03% shot up 45.7% in premarket trading Wednesday, after the biopharmaceutical company said the Food and D...

December 28, 2022, 6:48 am


Search within

Pages Search Results: